REGN

#254
Regeneron Pharmaceuticals, Inc. - Common Stock
619.4 2 USD
-0.34%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
617.80
624.47
Range Annuel
476.48
821.11
Changement quotidien
-0.34%
Changement Mensuel
-10.63%
Evolution sur 6 mois
-20.17%
Changement Annuel
+20.04%
Clôture Précédente
621.5 2
Open
620.1 1
Low
617.8 0
High
624.4 7
Volume
685
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 64.94 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
18.61
ratio cours/chiffre d'affaires
5.84

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Nouvelles